Insulin prescribing pattern in geriatric type 2 diabetic mellitus patients of different nutritional status at a tertiary level of health care: a retrospective study


  • Deidre L. Dias Department of Pharmacology, Goa Medical College and Hospital, Bambolim, Goa, India
  • Edwin J. Gomes Department of Medicine, Goa Medical College and Hospital, Bambolim, Goa, India



Elderly, Geriatric, Insulin, Type 2 diabetes mellitus


Background: The world, specifically India is witnessing a steady increase in elderly population. The numbers are expected to escalate by 3 million by 2050 considering India alone. Further, the diabetic population is also increasing, and India will be home to the highest population of diabetic patients. It is thus indispensable to understand the prescribing patterns in elderly diabetics where insulin is inevitably added later in the course of diabetes, if not earlier.

Methods: Data was extracted from a diabetic registry maintained of patients attending the outpatient departments of a tertiary health care between 2009 to 2012 and having completed one year of regular three-monthly follow ups. Data was entered into MS Excel, analysed using IBM SPSS software and presented in the form of percentages or averages.

Results: Out of the total 180 male predominated type 2 diabetics aged 60 years and above, 142 (78.8%) elderly patients received a single type of insulin each day. 102 (56.6%) patients were on human insulins while 82 (45.5%) were receiving analogues. As for premixed insulins, 62 (34.4%) patients were receiving biphasic insulin analogues, while 83 (46.1%) patients were receiving human premixed insulin.

Conclusions: The elderly population makes up for a huge proportion and is set to increase in the coming years. The insulin prescribing pattern in them needs to be tailor-made to suit their needs and preferences whilst maintaining a relaxed target of HbA1c control at 8mg% or less. However, it should not be too low so as to avoid unnecessary hypoglycaemic episodes.


International Diabetes Federation. IDF SEA members. Available at: Accessed on 7 January 2019.

World Health Organization. Diabetes, 2018. Available at: Accessed on 7 January 2019.

Kaveeshwar SA, Cornwall J. The current state of diabetes mellitus in India. Australas Med J. 2014 Jan 31;7(1):45-8.

Gupta R, Misra A. Type 2 diabetes in India: regional disparities. Brit J Diab Vas Dis. 2007 Jan;7(1):12-6.

Mohan V, Mathur P, Deepa R, Deepa M, Shukla DK, Menon GR, et alc. Urban rural differences in prevalence of self-reported diabetes in India-The WHO-ICMR Indian NCD risk factor surveillance. Diab Res Clin Prac. 2008 Apr 1;80(1):159-68.

World Health Organization. Diabetes, scale up prevention, strengthen care and enhance surveillance, 2016. Available at: mediacentre/events/world_health_day/whd-technical-paper-4-april.pdf?ua=1. Accessed on 7 January 2019.

Levin PA, Wei W, Zhou S, Xie L, Baser O. Outcomes and treatment patterns of adding a third agent to 2 OADs in patients with type 2 diabetes. J Managed Care Pharm. 2014 May;20(5):501-12.

Association AD. Glycemic Targets: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018 Jan 1;41(Supplement 1):S55-64.

Diabetes.Co.UK: the global diabetes community. Multiple dose insulin injection therapy-multiple daily injections. Available from: Accessed on 7 January 2019.

Yamamoto-Honda R, Takahashi Y, Mori Y, Yamashita S, Yoshida Y, Kawazu S, et al. Changes in antidiabetic drug prescription and glycemic control trends in elderly patients with type 2 diabetes mellitus from 2005-2013: an analysis of the national center diabetes database (NCDD-03). Intern Med. 2018 May 1;57(9):1229-40.

Lipska KJ, Yao X, Herrin J, McCoy RG, Ross JS, Steinman MA, et al. Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006-2013. Diabetes Care. 2017;40(4):468-75.

Clemens KK, Shariff S, Liu K, Hramiak I, Mahon JL, McArthur E, Garg AX. Trends in antihyperglycemic medication prescriptions and hypoglycemia in older adults: 2002-2013. PloS one. 2015 Sep 3;10(9):e0137596.

Kim HM, Seong JM, Kim J. Risk of hospitalization for hypoglycemia among older Korean people with diabetes mellitus: Interactions between treatment modalities and comorbidities. Medicine. 2016 Oct;95(42).

Selvin E, Parrinello CM, Daya N, Bergenstal RM. Trends in insulin use and diabetes control in the US: 1988-1994 and 1999-2012. Diabetes Care. 2016 Mar;39(3):e33-5.

Baruah MP, Kalra S, Bose S, Deka J. An audit of insulin usage and insulin injection practices in a large Indian cohort. Indian J Endocrinol Metab. 2017 May 1;21(3):443.

Alvarsson M, Sundkvist G, Lager I, Henricsson M, Berntorp K, Fernqvist-Forbes E, et al. Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients. Diabetes Care. 2003 Aug 1;26(8):2231-7.

Kumar Shrestha H, Tamrakar R, Shrestha A, Amatya SR. Insulin Prescription Pattern among Type 2 DM patients visiting Outpatient Department at a Tertiary Hospital in Kathmandu, Nepal. J Diabetes Endo Assoc Nepal. 2018;1(1):3-7.




How to Cite

Dias, D. L., & Gomes, E. J. (2019). Insulin prescribing pattern in geriatric type 2 diabetic mellitus patients of different nutritional status at a tertiary level of health care: a retrospective study. International Journal of Basic & Clinical Pharmacology, 8(3), 584–588.



Original Research Articles